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Introduction
Colorectal cancer represents nearly 10% of 
global cancer incidence, with increasing rates 
over the last decades (Bosman et al. 2014). 
Intake of total energy, red and processed 
meat, and alcoholic drinks together with 
physical inactivity, body fat, abdominal fat, 
and adult-attained height are established risk 
factors [Bosman et al. 2014; World Cancer 
Research Fund (WCRF) and American 
Institute for Cancer Research (AICR) et al. 
2011]. Suggested protective factors include 
consumption of dietary fiber and high fruit 
and vegetable consumption (WCRF and 
AICR et al. 2011; Bradbury et al. 2014), 
among others. However, part of the burden 
of disease remains unexplained by the above-
mentioned risk factors. Human and animal 
studies suggest that carcinogens in drinking 
water may be associated with colorectal 
cancer risk (Rahman et al. 2010).
Dis infect ion by-products  (DBPs) 
are chemicals resulting from disinfection 
processes that are widespread in drinking 
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Background: Evidence on the association between colorectal cancer and exposure to disinfection 
by-products in drinking water is inconsistent.
oBjectives: We assessed long-term exposure to trihalomethanes (THMs), the most prevalent 
group of chlorination by-products, to evaluate the association with colorectal cancer.
Methods: A multicenter case–control study was conducted in Spain and Italy in 2008–2013. 
Hospital-based incident cases and population-based (Spain) and hospital-based (Italy) controls were 
interviewed to ascertain residential histories, type of water consumed in each residence, frequency 
and duration of showering/bathing, and major recognized risk factors for colorectal cancer. We 
estimated adjusted odds ratios (OR) for colorectal cancer in association with quartiles of estimated 
average lifetime THM concentrations in each participant’s residential tap water (micrograms/liter; 
from age 18 to 2 years before the interview) and estimated average lifetime THM ingestion from 
drinking residential tap water (micrograms/day).
results: We analyzed 2,047 cases and 3,718 controls. Median values (ranges) for average lifetime 
residential tap water concentrations of total THMs, chloroform, and brominated THMs were 30 
(0–174), 17 (0–63), and 9 (0–145) μg/L, respectively. Total THM concentration in residential tap 
water was not associated with colorectal cancer (OR = 0.92, 95% CI: 0.66, 1.28 for highest vs. lowest 
quartile), but chloroform concentrations were inversely associated (OR = 0.31, 95% CI: 0.24, 0.41 for 
highest vs. lowest quartile). Brominated THM concentrations showed a positive association among 
men in the highest versus the lowest quartile (OR = 1.43, 95% CI: 0.83, 2.46). Patterns of association 
were similar for estimated average THM ingestion through residential water consumption.
conclusions: We did not find clear evidence of an association between detailed estimates of 
lifetime total THM exposure and colorectal cancer in our large case–control study population. 
Negative associations with chloroform concentrations and ingestion suggest differences among 
specific THMs, but these findings should be confirmed in other study populations.
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water. Trihalomethanes (THMs) are among 
the most prevalent DBPs and are highly 
volatile and skin permeable; exposure occurs 
through inhalation, dermal absorption, and 
ingestion (Ashley et al. 2005; Gordon et al. 
2006). The four THMs in drinking water 
that are regulated in the United States, 
European Union, and other countries are 
chloroform, bromodichloromethane, dibro-
mochloromethane, and bromoform; these 
chemicals display different physicochemical 
and toxicological properties. Chloroform 
is highly volatile, whereas the other three 
compounds (from now on referred to as 
brominated THMs) are more lipophilic and 
genotoxic (Plewa et al. 2008). Metabolism 
of DBPs is mediated by enzymes from the 
cytochrome P450 (CYP) and glutathione 
S-transferase (GST) families. In a hospital-
based case–control study, polymorphisms in 
CYP2E1, GSTT1 and GSTZ1 were found to 
modify associations between bladder cancer 
and DBP exposure (Cantor et al. 2010).
Animal studies have suggested an asso-
ciation between DBP exposure and colorectal 
cancer. Preneoplastic lesions have been 
produced in the intestines of rodents admin-
istered DBPs via drinking water in chronic 
bioassays (DeAngelo et al. 2002; McDorman 
et al. 2003). However, some studies have 
shown that chloroform may inhibit gastro-
intestinal carcinogenecity in rodents (Daniel 
et al. 1989, 1991). Human epidemiological 
evidence is mixed. Case–control (Bove et al. 
2007; Cragle et al. 1985; Hildesheim et al. 
1998; King et al. 2000; Young et al. 1987) 
and cohort (Doyle et al. 1997; Koivusalo 
et al. 1997) studies including incident cases 
of colorectal cancer and quantitative estimates 
of exposure to DBPs such as trihalometh-
anes or related surrogates have produced 
contradictory results (see Table S1). Three 
studies reported positive associations with 
colon cancer (Cragle et al. 1985; Doyle et al. 
1997; King et al. 2000), and three studies 
reported null associations (Hildesheim et al. 
1998; Koivusalo et al. 1997; Young et al. 
1987). Similarly, two studies reported positive 
associations with rectal cancer (Bove et al. 
2007; Hildesheim et al. 1998), and three 
reported null associations (Doyle et al. 1997; 
King et al. 2000; Koivusalo et al. 1997). 
The exposure assessments differed, with five 
studies evaluating THMs (Bove et al. 2007; 
Doyle et al. 1997; Hildesheim et al. 1998; 
King et al. 2000; Young et al. 1987) and one 
each evaluating years living in households 
with chlorinated water (Cragle et al. 1985) 
and water mutagenicity (Koivusalo et al. 
1997). The inconsistency of human epidemi-
ological evidence might be partly attributable 
to exposure misclassification, including a lack 
of evaluation of different routes of exposure 
and uncontrolled confounders.
Here, we examined the association 
between THM exposure and colorectal cancer 
in a large multicenter case–control study 
considering specific THM components and 
exposure activities involving dermal contact, 
inhalation, and ingestion.
Methods
Study Design and Population
Spain. We conducted a multicase–control 
study from September 2007 to November 
2013 in nine provinces of Spain (MCC-Spain 
project) including colorectal, prostate, 
breast, and gastroesophageal cancer and 
chronic lymphocytic leukemia cases and a 
common pool of population-based controls 
(Castaño-Vinyals et al. 2015). Cases included 
in the present analysis were histologically 
confirmed incident colorectal cancer patients 
[International Statistical Classification of Diseases 
and Related Health Problems (10th revision) 
(ICD-10): C18, C19, C20, D01.0, D01.1, 
D01.2]. Cases were interviewed as soon as 
possible after diagnosis (median of 58 days) 
and were identified through active searches 
including periodic visits to hospital depart-
ments (i.e., gastroenterology, oncology, 
general surgery, radiotherapy, and pathology). 
Minimal losses occurred from cases dying 
before being contacted (0.5% of potentially 
eligible cases). Controls were frequency 
matched to cases by sex, age (± 5 years), and 
area of residence, ensuring that in each area 
there was at least one control of the same sex 
and 5-year interval for each case. Controls 
were selected from the general population in 
each study area and were identified from the 
lists of randomly selected family practitio-
ners in primary assistance centers sharing the 
catchment area of the participating hospital. 
This procedure ensured the identification of 
controls from the general population and from 
the same study base as cases, through the social 
security records (health coverage is universal in 
Spain), with the advantage that the telephone 
contacts by the study personnel on behalf of 
the family practitioner increased the response 
rate compared with other procedures (Castaño-
Vinyals et al. 2011). For each control needed, 
five potential participants of similar age, sex, 
and hospital catchment area were randomly 
selected from the general practitioner lists. If 
contact was not made with the first person 
on the list after five tries at different times of 
day, or if he/she refused to participate, the next 
person on the list was approached (Castaño-
Vinyals et al. 2011). The frequency matching 
was done separately for each study area, 
considering the age and sex distribution of the 
total number of cases recruited. Thus, the final 
number of controls in the present analysis is 
greater than the number of cases because the 
controls were matched to different cancer sites.
Italy. We conducted a case–control 
study of colorectal cancer in three provinces 
of Italy (Milan, Pordenone, Udine) between 
January 2008 and July 2010 (Hiwate Project) 
(Nieuwenhuijsen et al. 2009). Cases were 
histologically confirmed incident colorectal 
cancer patients (ICD-10: C18, C19, C20) 
who were interviewed as soon as possible 
after diagnosis (median of 28 days) and were 
identified through active searches including 
periodic visits to hospital departments (i.e., 
gastroenterology, oncology, general surgery, 
radiotherapy, and pathology). Controls 
were frequency matched to cases by sex, age 
(± 5 years), and area of residence, with a 
case:control ratio of 1. Controls were iden-
tified from patients admitted to the same 
network of hospitals as cases for a wide 
spectrum of acute, non-neoplastic conditions 
unrelated to tobacco and alcohol consump-
tion, long-term diet modification, and other 
factors likely related to colorectal cancer. 
Overall, 52% of controls had acute surgical 
conditions, 15% had orthopedic disorders, 
12% had dental, ear, nose and throat diseases, 
and 21% had miscellaneous other conditions.
In both countries, study participants were 
20–85 years old, had resided in the hospital 
catchment area for ≥ 6 months before recruit-
ment, and were able to answer the epidemio-
logical questionnaire. Participant hospitals 
(17 in Spain, 10 in Italy) were the reference 
centers for oncologic diseases in each study 
area. The study protocol was approved by 
the ethics review boards of the participating 
centers, and all participants signed an 
informed consent before recruitment.
Data Collection and Response Rates
Trained interviewers administered question-
naires to collect personal information on 
sociodemographic factors; lifestyle (smoking, 
alcohol consumption, physical activity, etc.); 
anthropometrics (height, weight); residential 
history; type of water consumed in each resi-
dence (municipal, bottled, other); frequency 
of showering, bathing, and hand dishwashing; 
occupation; medication; medical history; and 
family history of cancer. Amount of water 
ingested was ascertained as the number of 
glasses per day consumed on average by an 
adult at home, at the workplace and in other 
places; bottled water, municipal water, water 
from other sources, coffee, tea, and herbal 
drinks were considered separately. A final 
section evaluating the quality of the interview 
was completed by the interviewer. Dietary 
habits were collected through semiquantita-
tive food frequency questionnaires that were 
self-administered in Spain and administered 
by an interviewer in Italy. Sample size was 
fixed by the primary scientific objectives of 
the MCC-Spain Study (Castaño-Vinyals 
et al. 2015). Before any analysis, we used data 
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from the literature on total THM distribution 
(Villanueva et al. 2012) to calculate [using the 
program GRANMO 7.12 (Marrugat et al. 
1998)] that the statistical power was 100%, 
assuming a difference of 4 μg/L between cases 
and controls (based on current preliminary 
data), and accepting an alpha risk of 0.05 in a 
two-sided contrast. Response rates were calcu-
lated as follows: subjects interviewed were 
in the numerator, and all subjects including 
refusals were in the denominator. The average 
response rates were 68% in Spain and 95% 
in Italy among cases, and 53% in Spain 
and 95% in Italy among controls. In total, 
2,371 cases (1,905 in Spain, 466 in Italy) and 
4,159 controls (3,590 in Spain, 569 in Italy) 
were interviewed.
Trihalomethane Levels in the 
Study Areas
We used trihalomethanes as a surrogate of 
DBPs. We collected routine THM measure-
ments (chloroform, bromodichloro methane, 
dibromochloromethane, and bromoform) 
and historical information on water sources 
(surface/ground proportion) and treatment 
in the drinking water supplied to the study 
areas back to 1940 through a structured ques-
tionnaire aimed at water utilities and local 
and health authorities. Routine monitoring 
data were provided by the SINAC (Sistema de 
Información Nacional en Aguas de Consumo) 
in Spain (2004–2010) and by the Regional 
Environmental Health Agency (Milan) and the 
Local Health Authority (Pordenone/Udine) 
in Italy. Availability of THM measurements 
differed among study areas, with the longest 
record starting in 1979. In total, 275 water 
zones in Spain and 370 in Italy were included.
Estimation of Long-Term 
Trihalomethane Levels in 
Drinking Water
Annual average levels were calculated for the 
four THMs separately at the water zone level, 
that is to say, at the minimum geographic unit 
with homogeneous water source, treatment, 
and quality (corresponding to municipality 
in most cases). Cases and controls lived on 
average in three residences during the exposure 
window; therefore, cases and controls from an 
area had different and multiple water zones 
assigned. Years without measurements were 
assigned the average of all available measure-
ments in the water zone if the water source 
and treatment did not change over the years. 
Trihalomethane concentrations in surface 
water are usually higher than in ground 
sources (Villanueva et al. 2003), and we used 
surface water percentage as a weight to back-
extrapolate THM concentrations when water 
sources changed, assuming that concentrations 
increased proportionately to the percentage 
of surface water. The same assumptions were 
used for the four THMs and were applied 
uniformly in all water zones. Hypochlorite was 
the main disinfectant used in all of the study 
areas. Alternative or complementary treat-
ments identified in the study areas included 
permanganate, chlorine dioxide, and ozona-
tion. Water zones with THM measurements 
and changes in treatment over the years were 
used to estimate the change percentage in the 
four THMs separately after introducing such 
treatments. These percentages were applied 
as a weight to back-extrapolate concentra-
tions of the four THMs separately in areas 
with changes in these specific treatments for 
years when measurements were unavailable. 
Before chlorination started, THM concentra-
tions were assumed to be zero. The years when 
chlorination started varied widely among study 
areas, ranging from before 1940 (Asturias, 
Barcelona, Cantabria) to 2005 (a small munici-
pality in Valencia). Using these procedures, we 
estimated annual average THM levels by water 
zone back to 1940 in areas covering 83% of 
study person-years, ranging from 67% (León) 
to 95% (Gipuzkoa).
Individual Exposures in the Study 
Population
Average THM concentrations in residential 
tap water. Trihalomethane concentrations 
(micrograms/liter; considering the four 
THMs separately) and subjects’ personal data 
were linked by year and water zone of resi-
dence to obtain annual concentrations in the 
residences where subjects lived from age 18 
to 2 years before the interview (henceforth 
referred to as “lifetime”). The average concen-
tration in all residences with THM estimates 
was then calculated.
Average THM ingestion. The average 
THM ingestion (micrograms/day) was esti-
mated by calculating the average residential 
THM concentration assuming a zero level in 
residences consuming bottled water [based 
on a report by Font-Ribera et al. (2010)] 
and 0.3, 0.3, 0.8, and 1.8 μg/L for chloro-
forom, bromodichloromethane, dibromo-
chloromethane, and bromoform, respectively, 
in residences consuming private well water. 
These well-water values were averages of 
56 observations from water zones with 
chlorinated ground water in different areas 
(Gipuzkoa, Barcelona, Valencia, and Navarra) 
because we assumed that private well water 
was likely to be chlorinated. Municipal THM 
concentration was assigned to the years living 
in residences with municipal water consump-
tion. We averaged the THM concentration 
calculated using this procedure in residences 
from age 18 to 2 years before the interview 
and multiplied by the amount of water 
consumed at home (liters/day, assuming 
200 mL/glass). We used total water consumed 
at the residence (municipal, bottled, private 
well) because we did not have the specific 
amount by residence, and these habits may 
have changed over a participant’s life.
Showering and bathing THM exposure. 
We evaluated THM exposure through 
showering and bathing (micrograms/
liter × minutes/day) in terms of the average 
duration of showers and baths (minutes/
week) and the average THM concentration in 
residential tap water.
Genotyping
Blood or saliva samples were collected 
in all Spanish areas for DNA analysis. The 
response rate among those included in the 
present analysis was 93%, and DNA was 
obtained from 3,579 blood and 926 saliva 
samples. Owing to budget restrictions, geno-
typing was performed in a random sample 
of subjects (except in the Murcia area, where 
genotyping was not conducted) covering 
71% of the Spanish participants. Genome-
wide genotyping was performed using a 
customized version of the Infinium Human 
Exome BeadChip Kit v.1.1 (Illumina). 
A total of 5,363 single nucleotide poly-
morphisms (SNPs) of interest to the MCC 
study were added to the chip, for a total of 
248,264 markers. The genotype calling was 
performed using the GenTrain 2.0 algorithm 
(GenomeStudio software) based on CHARGE 
clusters (Grove et al. 2013). PLINK was used 
for the genetic data quality control (Purcell 
et al. 2007), and standard checks were 
performed: sample call rate, sex concordance, 
heterozygosity, relatedness, population strati-
fication, minimum SNP call rate of 95%, and 
departure from Hardy–Weinberg equilibrium 
(HWE) for each SNP tested among Spanish 
controls. After quality control, the final 
database included 232,396 SNPs, with 94,659 
monomorphic and 99,411 with a minor allele 
frequency (MAF) < 1%, 8,853 with MAF 
1–5%, and 29,473 with MAF > 5%. For the 
present analysis, we selected SNPs in CYP2E1 
and GSTZ1 genes based on prior work by 
Cantor et al. (2010). After genotyping quality 
controls, 22 SNPs in CYP2E1 and 7 SNPs in 
GSTZ1 were available for statistical analysis 
(see Table S2 for a complete list). Genetic 
data were available for 981 cases and 2,204 
controls, which corresponds to a random 
sample of participants from Spain.
Covariables
Smokers were defined as those smoking at least 
100 cigarettes or 360 g of tobacco in life on a 
regular basis, that is, at least one cigarette/day 
for ≥ 6 months. Former smokers were defined 
as those who quit smoking ≥ 1 year before the 
interview. Users of nonsteroidal antiinflam-
matory drugs (NSAIDs) were coded as ever 
(or never) users if subjects consumed (or not) 
NSAIDs at least 30 times over life. Physical 
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activity was ascertained through open ques-
tions on any type of physical activity practiced 
in life, the years and the frequency (hours/
week) converted to metabolic equivalents 
(METs) from age 16 (Spain) or 15 (Italy) to 
2 years before the interview. Cancer diagnosis 
(any type) in first-degree relatives was asked, 
and for positive responses, the type of cancer 
was ascertained. Family history of colorectal 
cancer was defined by self-reported malignant 
tumors (polyps excluded). Body mass index 
was calculated based on the weight 1 year 
before the interview and was categorized in 
three groups (< 25, 25–29.9, ≥ 30 kg/m2). 
A total of 156 food items were ascertained 
through a food frequency questionnaire, 
assessing usual dietary intake the year before 
the interview. Frequencies in servings/day 
of red meat, processed meat, dairy products, 
fruits, and vegetables were converted to 
grams/day based on food composition tables.
Statistical Analysis
Only subjects with average THM concen-
trations in the residential tap water, 
average THM ingestion, and average 
showering/bathing THM exposure estimates 
for ≥ 70% of the years between age 18 and 
2 years before the interview (89% of inter-
viewed subjects) were considered in the respec-
tive models, and subjects with unreliable 
interviews (n = 16) were excluded. Thus, a total 
of 5,765 subjects were included in the statis-
tical analyses (2,047 cases, 3,718 controls), of 
which 5,291 (1,837 cases, 3,454 controls) were 
analyzed for average THM concentrations in 
residential tap water and 5,731 (2,047 cases, 
3,684 controls) were analyzed for ingested 
THMs. The higher numbers for the ingestion 
variable are explained by those whose residen-
tial THM concentration cannot be estimated 
and who consumed bottled or private well 
water. We used unconditional logistic regres-
sion to estimate odds ratios (ORs) and 95% 
confidence intervals (CIs) for associations 
between colorectal cancer and THM expo-
sures adjusted for age (continuous), sex, area 
(as a factor in the model), education, smoking, 
use of NSAIDs, leisure physical activity, and 
family history of colorectal cancer (first-degree 
relatives), categorized as shown in Table 1. 
Missing values in categorical variables were 
coded as a separate category. There were no 
missing values for the matching variables (age, 
sex, area). Categories of body mass index and 
milligrams/day (continuous) of red meat, 
processed meat, dairy product, fruit, and vege-
table consumption were explored but did not 
meet our criterion for confounding (< 10% 
change in the risk estimates) and were omitted 
to keep the most parsimonious models. Given 
the different genotoxicity (Landi et al. 1999) 
and collinearity among THMs, analyses were 
conducted separately for chloro form and the 
brominated THMs (bromo dichloro methane, 
dibromochloromethane, and bromoform), 
and mutually adjusted ORs for both expo-
sures were not estimated. Exposure catego-
ries for both cases and controls were created 
according to quartiles of THM exposure 
overall. Linear p-trends were calculated using 
a likelihood-ratio test comparing the model 
with and without the exposure variable with 
numerically coded quartiles (0, 1, 2, 3). 
Table 1. Characteristics of the study population: 2,047 cases of colorectal cancer and 3,718 controls.
Variable
Cases 
n (%) or mean ± SD
Controls 
n (%) or mean ± SD
Age (years), mean (SD) 67 ± 10 64 ± 11 
Sex
Men 1,317 (64.3) 1,943 (52.3)
Women 730 (35.7) 1,775 (47.7)
Area  
Asturias (Spain) 70 (3.4) 211 (5.7)
Barcelona (Spain) 635 (31.0) 957 (25.7)
Cantabria (Spain) 125 (6.1) 282 (7.6)
Guipuzcoa (Spain) 113 (5.5) 329 (8.9)
León (Spain) 294 (14.4) 360 (9.7)
Madrid (Spain) 204 (10.0) 670 (18.0)
Murcia (Spain) 28 (1.4) 39 (1.1)
Navarra (Spain) 102 (5.0) 234 (6.3)
Valencia (Spain) 76 (3.7) 133 (3.6)
Milano (Italy) 215 (10.5) 301 (8.1)
Pordenone/Udine (Italy) 185 (9.0) 202 (5.4)
Education  
< Primary school 519 (25.4) 592 (15.9)
Primary school 766 (37.5) 1,234 (33.2)
Secondary school 566 (27.7) 1,182 (31.8)
University 190 (9.3) 707 (19.0)
Missing 6 3
Smoking status  
Never 841 (41.4) 1,629 (43.9)
Former 821 (40.4) 1,290 (34.8)
Current 371 (18.2) 789 (21.3)
Missing 14 10
Nonsteroidal antiinflammatory drug consumptiona
No 1,382 (69.7) 2,237 (62.3)
Yes 600 (30.3) 1,352 (37.7)
Missing 65 129
Body mass index (kg/m2)b  
< 25 676 (33.0) 1,391 (37.8)
25–29.9 909 (44.4) 1,555 (42.3)
≥ 30 461 (22.5) 734 (20.0)
Missing 1 38
Leisure physical activity (adult life average)c
0 METs 627 (30.6) 1,011 (27.4)
0–8 (8.5) METs 698 (34.1) 1,324 (35.9)
8–16 (34.4) METs 294 (14.4) 582 (15.8)
> 16 (34.4) METs 428 (20.9) 767 (20.8)
Missing 0 34
Family history of colorectal cancer (first degree) 
No 1,648 (85.4) 3,246 (92.0)
Yes 281 (15.6) 284 (8.0)
Missing 118 188
Drinking-water type at the place of longest residence
Tap (municipal) 1,185 (58%) 2,474 (67%)
Bottled 655 (32%) 1,014 (27%)
Private well 198 (10%) 227 (6%)
Missing 9 3
Number of residences 3.2 ± 1.5 3.3 ± 1.6
Years at the place of longest residence 35.6 ± 12.0 31.8 ± 12.1
Average THM concentration in residential tap water (μg/L)d 44.8 ± 43.9 40.3 ± 34.2
Average THM ingestion from residential tap water (μg/day) 28.1 ± 48.8 25.9 ± 36.4
Average showering/bathing THM concentrations (min/day × μg/L)e 284.7 ± 406.4 266.6 ± 311.5
Notes: MET, metabolic equivalent; THM, trihalomethane.
The table excludes subjects with inadequate THM exposure data and 16 observations with low-quality interviews.
aEver users consumed nonsteroidal antiinflammatory drugs ≥ 30 times in life.
bBody mass index based on the weight 1 year before the interview.
cCategories were country-specific, and cut-offs for Italy are in parentheses.
dNumber of observations: 1,977 cases, 3,679 controls.
eNumber of observations: 1,834 cases, 3,480 controls.
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Generalized additive models (GAMs) were 
used to evaluate the exposure–response rela-
tionships of continuous variables, using a 
smoothed spline with 3 degrees of freedom 
with the gam function in Stata release 12 
(StataCorp LP). Departure from linearity was 
assessed by testing the difference in normal-
ized deviance between the GAM and a model 
with a linear term for the exposure, based on 
a chi-squared approximation. Other exposure 
variables examined included the type of water 
consumed at the place of longest residence and 
showering/bathing frequency combined with 
THM concentrations (minutes/day × micro-
grams/liter). The main analyses were strati-
fied by sex, given the higher incidence among 
men, expected differences in established risk 
factors, and for comparability with previous 
studies. We explored potential differences by 
cancer site (colon, rectum) in stratified analyses 
for comparability with previous studies. The 
p-value threshold defining statistical signifi-
cance was set at < 0.05. Interactions between 
lifetime average THM concentrations at the 
residence (dichotomized at the 75th percen-
tile) and genotypes were examined to assess 
the odds ratios within genotype categories; the 
dominant model (heterozygous and homo-
zygous variant versus homozygous wild type) 
was used. We used the likelihood-ratio test 
to evaluate the joint effects of SNPs and the 
interaction term. Linkage disequilibrium was 
evaluated, and the number of effective tests 
with an R2 cut-off set at 0.8 was 15. Bonferroni 
corrections for number of effective tests were 
applied in genotype analyses.
Results
A total of 5,765 subjects were included in 
the present analysis: 1,647 cases and 3,215 
controls from Spain, and 400 cases and 
503 controls from Italy (Table 1). The area 
contributing with the largest population was 
Barcelona (28% of all subjects), followed 
by Madrid (15%). The proportion of men 
was higher among cases (64%) than controls 
(52%). Cancer location was colon for 1,410 
(69%) cases, rectum for 607 (30%) cases, 
Figure 1. Distribution of average residential trihalomethane (THM) exposure among subjects with THM estimates for ≥ 70% of the exposure window (age 
18 to 2 years before the interview) from reliable interviews. (A) Average concentrations at the tap (micrograms/liter), n = 5,291. (B) Average ingested levels 
( micrograms/day), n = 5,731. All areas correspond to Spain except Milano and Pordenone/Udine (Italy). Boxes are delimited by the 25th (left hinge) and 75th (right 
hinge) percentiles, the central vertical line represents the median value, the whiskers represent ± 1.5 times the interquartile range, and the points outside the 
whiskers represent outliers.
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and unspecified or missing for 30 (1%) cases. 
The proportions of smokers, participants 
with BMI > 25 kg/m2, and family history 
of colorectal cancer was higher among cases, 
whereas the proportion of NSAID users 
was higher among controls, and physical 
activity was similar among cases and controls 
(Table 1). Water type consumed in the place 
of longest residence, residential history, and 
THM exposure are presented in Table 1.
The concentration and composition 
of trihalomethanes differed between study 
areas (Figure 1). The median concentra-
tions overall were 29.5, 17.4, and 9.0 μg/L 
for residential total THMs, chloroform, and 
brominated THMs, respectively. Area median 
concentration of total THMs ranged from 
1 μg/L (Udine/Pordone, Italy) to 86 μg/L 
(Barcelona). Brominated THMs were highest 
in Murcia and Barcelona, with medians of 65 
and 64 μg/L, respectively, and chloroform 
was highest in Madrid (median 28 μg/L). 
Differences in ingested THMs among areas 
were less pronounced than concentrations of 
THMs in drinking water because the areas 
with higher THM concentrations usually 
had higher proportions of bottled water 
consumption. The Spearman correlation 
coefficients between total THMs versus chlo-
roform, bromodichloromethane, dibromoch-
loromethane, and bromoform were 0.68, 
0.87, 0.77, and 0.64, respectively. Between 
total brominated THMs and bromodichloro-
methane, dibromochloromethane and 
bromoform, the Spearman correlation coeffi-
cients were 0.96, 0.98, and 0.90, respectively. 
These correlations varied among study areas. 
Total THM–chloroform correlation was 
> 0.84 in all areas except Barcelona (–0.32). 
The distribution densities of average lifetime 
THM concentrations in residential tap water 
by case–control status and by area are shown 
in Figure S1.
Lifetime average total THM concentra-
tions were not positively associated with 
colorectal cancer among men or women, 
and a negative association was observed for 
some exposure categories in the low-exposure 
range (Table 2). Chloroform concentrations 
were negatively associated with colorectal 
cancer, with the strongest associations for 
the highest versus lowest quartile both 
among men and women. Brominated THM 
concentrations were positively associated with 
colorectal cancer among men in the highest 
versus lowest exposure category (OR = 1.43, 
95% CI: 0.83, 2.46) and negatively associated 
in the third versus lowest quartile (OR = 0.57, 
95% CI: 0.36 0.90) and among women 
(Table 2). Generalized additive models 
confirmed these patterns, revealing nonlinear 
exposure–response relationships (Figure 2). 
However, the curves have low precision at 
the high end of the exposure ranges, and 
the estimates are based on small numbers of 
subjects. Exposure–response curves for the 
four THMs, for men and women combined, 
are shown in Figure S2. Approximately linear 
negative associations are shown for chloro-
form and positive associations are shown 
for bromoform, whereas the associations for 
bromo dichloromethane and dibromochloro-
methane are nonlinear. Associations by area 
were heterogeneous, with Barcelona showing 
similar results to the overall estimates (see 
Figures S3 and S4). Conversely, models with 
all areas except Barcelona show attenuated 
dose–response relationships (see Figures S3 
and S4), indicating that Barcelona, with ~26% 
of all controls, ~31% of all cases, and observa-
tions in the highest quartiles of brominated 
THMs, drives the overall results.
Interactions between exposure to total 
and brominated THMs and 22 selected 
polymorphisms were evaluated. Nominal 
statistically significant interactions were 
observed between four SNPs in the CYP2E1 
gene (rs2070675, rs915907, rs8192775, and 
rs743535) in relation to colorectal cancer and 
exposure to brominated THMs at concentra-
tions > 40 μg/L (Table 3); however, none 
was statistically significant according to the 
Bonferroni-corrected p-value (0.03). Owing 
to changes in the reference category and in 
the sample with genetic data, the ORs for 
the highest quartile versus quartiles 1–3 
combined are ~ 2–4 for brominated and total 
THMs (Table 3). The results for all SNPs 
analyzed in relation to different exposure 
cut-offs for total, chlorinated, and brominated 
THMs are shown in Table S2.
The use of bottled water versus municipal 
water at the place of longest residence (33 years 
long on average) was positively associated with 
colorectal cancer among men and women 
combined [OR = 1.19 (95% CI: 1.04, 1.37)], 
among men [OR = 1 .17 (95% CI: 
0.98, 1.39)], and among women [OR = 1.20 
(95% CI: 0.96, 1.50)]. Ingested chloro form 
level was negatively associated with colorectal 
cancer among men and women (Table 4). 
Ingested brominated THMs led negative asso-
ciations among women and among men in 
quartiles 2 and 3 versus quartile 1, whereas 
a positive association was observed among 
men in quartile 4 versus quartile 1 (Table 4). 
Generalized additive models confirmed these 
Table 2. Association between average trihalomethane (THM) concentrations in residential tap water and colorectal cancer. Odds ratios (ORs) and 95% confi-
dence intervals (CIs) among 1,837 cases and 3,454 controls.
Exposure
All (n = 5,291) Men (n = 2,977) Women (n = 2,312)a
Cases Controls ORb (95% CI) Cases Controls ORb (95% CI) Cases Controls ORb (95% CI)
Total THMs (μg/L) 
< 16.2 591 741 1 393 447 1 196 294 1
16.2–29.5 378 954 0.57 (0.45, 0.72) 241 407 0.56 (0.41, 0.77) 137 547 0.62 (0.41, 0.93)
29.5–62 323  1,007 0.44 (0.33, 0.58) 193 530 0.38 (0.27, 0.55) 130 477 0.60 (0.38, 0.93)
> 62 545 752 0.92 (0.66, 1.28) 349 417 1.04 (0.68, 1.60) 196 335 0.68 (0.39, 1.20)
p-Trendc 0.187 0.741 0.165
Chloroform (μg/L)
< 6 589 744 1 387 446 1 200 298 1
6–17.4 435 895 0.69 (0.55, 0.87) 268 404 0.69 (0.51, 0.93) 167 491 0.71 (0.49, 1.03)
17.4–23.4 515 798 0.68 (0.53, 0.87) 335 384 0.73 (0.53, 1.01) 180 414 0.65 (0.43, 0.97)
> 23.4 298  1,017 0.31 (0.24, 0.41) 186 567 0.26 (0.18, 0.37) 112 450 0.46 (0.29, 0.72)
p-Trendc < 0.001 < 0.001 0.001
Brominated THMs (μg/L) 
< 3.7 541 792 1 348 483 1 191 309 1
3.7–9.0 387 943 0.77 (0.60, 0.98) 238 419 0.73 (0.53, 1.01) 149 524 0.78 (0.52, 1.17)
9.0–41.8 368 963 0.55 (0.38, 0.79) 241 479 0.57 (0.36, 0.90) 127 484 0.49 (0.26, 0.91)
> 41.8 541 756 1.00 (0.65, 1.53) 349 420 1.43 (0.83, 2.46) 192 336 0.44 (0.21, 0.92)
p-Trendc 0.556 0.036 0.039
aTwo female cases were excluded from the sex-stratified model because one category in education does not have observations among controls and was dropped from the model.
bAdjusted for sex, age, area, education, nonsteroidal antiinflammatory drug consumption, smoking, physical activity, and family history of colorectal cancer. The analysis excludes 
subjects with poor or questionable interviews and with known THM concentrations for < 70% of the exposure window (from age 18 to 2 years before the interview).
cLinear trend p-value, derived from a likelihood-ratio test comparing a model with the categorical nitrate variable as an ordinal variable (0, 1, 2), with a model that excluded the variable.
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patterns (see Figure S5), although the curves 
at the high end of the exposure range have low 
precision, and the estimates are based on small 
numbers of subjects.
When shower/bath duration was combined 
with THM concentrations, positive associa-
tions were observed for the highest exposure to 
brominated THMs among men and null to 
protective associations were observed for 
 chloroform (Table 5; see also Figure S6).
By cancer site, associations for colon and 
rectal cancer evaluated separately showed 
similar patterns particularly among men, 
although slight differences appeared among 
women (see Table S3). However, a majority 
of cases (69%) were colon cancers, and 
the number of cases of rectal cancer were 
particularly small among women, leading to 
 imprecise estimates.
Discussion
We estimated long-term exposure to four 
trihalomethanes in drinking water in a large 
multicenter case–control study of colorectal 
cancer, including areas with contrasting 
THM concentrations and evaluating different 
routes of exposure. In accord with some 
experimental evidence, chloroform concentra-
tions were inversely associated with colorectal 
cancer in men and women. A positive associa-
tion with colorectal cancer was only identified 
in the highest exposure category of bromi-
nated THM concentrations among men. 
Similar associations were found for colon and 
rectal cancer analyzed separately.
Evidence of  DBP carcinogenicity 
in animals differs by chemical, animal 
species, organ, and administration route. 
Increased incidence of preneoplastic lesions 
Table 3. Interaction between polymorphisms in CYP2E1 and trihalomethane (THM) exposure, dichotomized at the 75th percentile. Odds ratios (ORs) and 95% 
confidence intervals (CIs) among 981 cases and 2,204 controls.
Gene, SNPa Genotype Cases Controls
Total THMs  
(> vs. ≤ 60 μg/L)
Brominated THMs  
(> vs. ≤ 40 μg/L)
Chloroform  
(> vs. ≤ 20 μg/L)
OR (95% CI)b Nominal p-valuec OR (95% CI)b Nominal p-valuec OR (95% CI)b Nominal p-valuec
rs2070675 CC 682 1,496 3.5 (2.4, 5.1) 0.029 4.1 (2.7, 6.0) 0.009 0.4 (0.3, 0.6) 0.646
CT/TT 298 707 2.3 (1.3, 4.0) 2.1 (1.2, 3.7) 0.6 (0.4, 0.9)
rs915907 CC 710 1,566 3.3 (2.2, 4.7) 0.031 3.9 (2.7, 5.8) 0.009 0.4 (0.3, 0.5) 0.392
AC/AA 252 618 2.6 (1.4, 5.0) 2.3 (1.2, 4.3) 0.8 (0.5, 1.2)
rs8192775 GG 850 1,884 3.1 (2.2, 4.4) 0.103 3.7 (2.6, 5.3) 0.021 0.5 (0.4, 0.6) 0.383
AG/AA 131 320 2.7 (1.1, 6.5) 1.7 (0.8, 3.9) 0.5 (0.2, 1.0)
rs743535 GG 838 1,823 3.0 (2.1, 4.3) 0.056 3.7 (2.6, 5.3) 0.019 0.5 (0.3, 0.6) 0.066
AG/AA 142 381 3.4 (1.5, 7.8)  2.0 (0.9, 4.3)  0.5 (0.3, 0.9)
Notes: SNP, single nucleotide polymorphism.
aResults for all SNPs are reported in Table S2.
bAdjusted for sex, age, geographical area and education.
cLikelihood-ratio test for the joint effect of the SNP and interaction term. Critical p-value with Bonferroni corrections, p < 0.003.
Figure 2. Exposure–response relationship between residential trihalomethane (THM) concentrations (x-axis, in micrograms/liter) and colorectal cancer (y-axis, 
expressed as odds ratios, ORs) among 1,837 cases and 3,454 controls. (A) Men. (B) Women.
Smoothed spline with 3 degrees of freedom from general additive models adjusted for sex, age, area, education, smoking, physical activity, nonsteroidal antiinflammatory drug use, 
and family history of cancer. Subjects with unsatisfactory questionnaires and subjects with THMs estimated for < 70% of the exposure window were excluded. p-Value gain com-
pared with linearity is < 0.001 for all models, except for chloroform in women (p-value = 0.38). Tick marks above the x-axes represent observations, and the dashed lines represent the 
95% confidence intervals (CIs).
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was found in the colon of rats exposed 
to chloroform, bromodichloromethane, 
dibromo chloromethane, bromoform, and 
3-chloro-4-(dichloromethyl)-5-hydroxy-
2(5H)-furanone (MX), individually and in 
mixtures (McDorman et al. 2003), but was 
not observed in mice (DeAngelo et al. 2002). 
Among THMs, bromodichloromethane 
administered by gavage caused the widest 
spectrum of neoplasms in rodents, including 
in the large intestine (Dunnick et al. 1987). 
However, another study found resistance in 
the intestinal tract to the effects of MX on 
preneoplastic or neoplastic development 
despite the elevated MX genotoxicity observed 
in the gastrointestinal (GI) tract (Steffensen 
et al. 1999). Specific evidence on gastroin-
testinal carcinogenicity has shown that chlo-
roform inhibits chemically induced tumors 
(Daniel et al. 1989) and nuclear anomalies 
(Daniel et al. 1991) in rodents exposed to 
GI carcinogens. More recently, chloroform 
was identified as the active component of an 
herbal drug used to treat cancer (Zhang et al. 
2014; Yu et al. 2007), and the chloroform 
fraction of a traditional drug used in Asia has 
shown antitumor activity (Habib and Karim 
2011). Although the mechanisms are not 
known, a possible explanation would involve 
selectively destroying the initiated cells (Reddy 
et al. 1992) through apoptosis and supres-
sion of proliferation (Zhang et al. 2014). 
Finally, the association with chloroform 
should be cautiously interpreted and remains 
to be confirmed.
Approximately 11% of the study popu-
lation had exposures above the maximum 
contaminant levels for total THMs in Spain 
(100 μg/L); the maximum concentration 
observed was 174 μg/L, and most of these 
high exposures were clustered in the area of 
Barcelona (97%) followed by Murcia (3%). 
Table 5. Association between colorectal cancer and shower/bath trihalomethane (THM) levels. Odds ratios (ORs) and 95% confidence intervals (CIs) among 
1,702 cases and 3,269 controls.
Exposure
All (n = 4,971) Men (n = 2,793) Women (n = 2,176)a
Cases Controls ORb (95% CI) Cases Controls ORb (95% CI) Cases Controls ORb (95% CI)
Total THMs (μg/L × min/day) 
< 60.7 550 701 1 363 444 1 185 257 1
60.7–158.7 382 867 0.72 (0.58, 0.89) 244 420 0.76 (0.58, 0.99) 138 447 0.67 (0.47, 0.97)
158.7–336.7 329 920 0.60 (0.48, 0.76) 203 416 0.68 (0.50, 0.92) 126 504 0.54 (0.37, 0.80)
> 336.7 441 781 0.81 (0.63, 1.06) 279 424 0.92 (0.65, 1.29) 162 357 0.71 (0.46, 1.09)
p-Trendc 0.121 0.426 0.141
Chloroform (μg/L × min/day)
< 26.1 550 701 1 361 435 1 188 266 1
26.7–72.5 444 804 0.85 (0.70, 1.03) 284 405 0.90 (0.70, 1.16) 159 399 0.82 (0.59, 1.13)
72.5–143.5 373 861 0.65 (0.53, 0.81) 237 445 0.68 (0.51, 0.89) 136 416 0.68 (0.48, 0.97)
> 143.5 335 903 0.66 (0.52, 0.83) 207 419 0.73 (0.54, 0.99) 128 484 0.60 (0.41, 0.88)
p-Trendc < 0.001 0.016 0.007
Brominated THMs (μg/L × min/day)
< 16.5 539 712 1 345 455 1 192 257 1
16.5–51.0 339 911 0.66 (0.53, 0.83) 217 431 0.76 (0.57, 1.01) 122 480 0.52 (0.36, 0.74)
51.0–178.0 345 904 0.61 (0.47, 0.80) 220 401 0.78 (0.56, 1.09) 125 503 0.43 (0.28, 0.65)
> 178 479 742 0.90 (0.65, 1.25) 307 417 1.25 (0.83, 1.89) 172 325 0.55 (0.32, 0.95)
p-Trendc 0.267 0.627 0.010
aTwo female cases were excluded from the sex-stratified model because one category in education did not have observations among controls and was dropped from the model. 
bAdjusted for sex, age, geographical area, education, nonsteroidal antiinflammatory drug consumption, smoking, physical activity, and family history of colorectal cancer. The analysis 
excluded subjects with poor or questionable interviews and with known THM levels for < 70% of the exposure window (from age 18 to 2 years before the interview).
cLinear trend p-value, derived from a likelihood-ratio test comparing a model with the categorical nitrate variable as an ordinal variable (0, 1, 2) with a model that excluded the variable.
Table 4. Association between average trihalomethane (THM) ingestion in the residence and colorectal cancer. Odds ratio (ORs) and 95% confidence intervals 
(CIs) among 2,047 cases and 3,684 controls.
Exposure
All (n = 5,731) Men (n = 3,239) Women (n = 2,490)a
Cases Controls ORb (95% CI) Cases Controls ORb (95% CI) Cases Controls ORb (95% CI)
Total THMs (μg/day) 
< 1.3 601 836 1 390 491 1 209 345 1
1.3–12.2 555 882 0.98 (0.83, 1.17) 372 448 0.99 (0.79, 1.25) 183 434 1.04 (0.78, 1.39)
12.2–32.3 395 1,039 0.74 (0.61, 0.91) 245 474 0.74 (0.58, 0.96) 150 565 0.83 (0.60, 1.14)
> 32.3 496 927 0.83 (0.68, 1.00) 310 509 0.82 (0.64, 1.05) 186 418 0.86 (0.63, 1.17)
p-Trendc 0.008 0.034 0.176
Chloroform (μg/day)
< 0.2 621 816 1 403 471 1 216 345 1
0.2–5.3 537 897 0.87 (0.74, 1.03) 356 489 0.86 (0.70, 1.05) 181 408 0.98 (0.75, 1.29)
5.3–16.6 477 955 0.82 (0.69, 0.98) 310 435 0.89 (0.71, 1.12) 167 520 0.78 (0.58, 1.04)
> 16.6 412 1,016 0.67 (0.56, 0.82) 248 527 0.63 (0.49, 0.81) 164 489 0.74 (0.54, 1.01)
p-Trendc < 0.001 0.001 0.031
Brominated THMs (μg/day) 
< 0.7 590 847 1 384 496 1 204 351 1
0.7–3.7 521 918 1.04 (0.86, 1.26) 332 467 0.99 (0.78, 1.26) 189 451 1.26 (0.91, 1.74)
3.7–11.9 412 1,024 0.79 (0.65, 0.96) 262 460 0.76 (0.59, 0.98) 150 564 0.85 (0.61, 1.19)
> 11.9 524 895 0.83 (0.68, 1.02) 339 499 0.88 (0.68, 1.14) 185 396 0.83 (0.60, 1.15)
p-Trendc 0.007 0.098 0.059
aTwo female cases were excluded from the sex-stratified model because one category in education did not have observations among controls and was dropped from the model. 
bAdjusted for sex, age, area, education, smoking, physical activity, nonsteroidal antiinflammatory drug consumption, and family history of cancer. Models excluded subjects with poor 
or questionable questionnaires and with THM ingestion estimated for < 70% of the exposure window (from age 18 to 2 years before the interview).
cLinear trend p-value, derived from a likelihood-ratio test comparing a model with the categorical nitrate variable as an ordinal variable (0, 1, 2) with a model that excluded the variable.
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In Italy, all study subjects were below the 
regulatory limits (30 μg/L). Specific THMs 
are not regulated in Italy or in Spain [Diario 
oficial Boletín Oficial del Estado (BOE) 2003; 
Gazzetta Ufficiale della Repubblica Italiana 
(GURI) 2001]. The highest exposure catego-
ries defined in previous studies were ≥ 75 μg/L 
(King et al. 2000), ≥ 46.4 μg/L (Hildesheim 
et al. 1998) and > 40 μg/L (Young et al. 
1987), all of which were included in the 
range of our study. The case–control study by 
Bove et al. (2007), which included only men, 
showed a median chloroform concentration 
(17.6 μg/L) similar to our median concen-
tration (17 μg/L). Our exposure periods are 
comparable to those of previous studies, which 
covered either lifetime (Hildesheim et al. 
1998; Young et al. 1987) or 40 years before 
the interview (King et al. 2000). However, 
the present study evaluated populations with 
higher concentrations of brominated THMs 
than did previous case–control or cohort 
studies evaluating colorectal cancer. Only one 
case–control study evaluated associations for 
brominated THMs (Bove et al. 2007), and 
it showed positive associations with rectal 
cancer. Our results are not consistent with 
those of a cohort study conducted by Doyle 
et al. (1997), in which the predominant THM 
was chloroform (geometric mean 46.1 μg/L 
in surface water, 82% from total THMs), and 
associations were estimated for this substance. 
They reported a positive association for colon 
cancer [Relative risk (RR) = 1.68, 95% CI: 
1.11, 2.53], and a null association for rectal 
cancer (RR = 1.07, 95% CI: 0.60, 1.93) for 
the highest exposure category (14–287 μg/L). 
To our knowledge, this is the first epidemio-
logical study reporting a negative association 
with chloroform. However, King et al. (2000) 
reported negative associations for some catego-
ries of total THM exposure among women, 
without a clear dose–response. Our findings 
showing different associations for specific 
THMs lead us to speculate that the use of 
total THMs without considering different 
DBP compositions could at least partly 
explain the heterogeneous results obtained in 
previous studies. Finally, the gut microbiota 
may play a role in colorectal carcinogenesis 
because chlorinated water has been shown to 
alter the enteric environment in mice (Sasada 
et al. 2015). This finding has received recent 
attention, and evidence is limited.
Whereas negative associations with chlo-
roform were found for both men and women, 
a positive association with brominated and 
total THMs was found among men at the 
high end of the exposure range, where there 
are few observations and precision is low. 
Similarly, previous studies have found incon-
sistent differences between men and women 
regarding colorectal cancer associated with 
THM exposure (King et al. 2000). Although 
associations were minimally modified by 
introducing covariables in the models (data 
not shown), residual confounding cannot 
be ruled out.
Exposure measurement error i s  a 
concern in cancer studies given the long 
exposure windows and limited historical 
THM measurements. In the present study, 
we applied different strategies to minimize 
measurement error for the exposures. Subjects 
included in the models had exposure estimates 
covering a major portion of the exposure 
window (≥ 70%). Because the quality of the 
interview is related to measurement error 
(Villanueva et al. 2009), we only analyzed 
subjects with reliable interviews. Finally, 
inability to account for THM exposure 
outside the home may have introduced error 
in the ingestion estimates for THMs, although 
most of the total water consumption occurred 
at home (74%).
We cannot rule out uncontrolled 
confounding by other water contaminants. 
However, long-term assessment of exposure to 
nitrate has been conducted following methods 
comparable to those used for trihalomethane 
exposure assessment (Espejo-Herrera et al. 
2016). Lifetime average nitrate concentra-
tions in the residence ranged approximately 
from 3 to 20 mg/L, and Pearson correla-
tion coefficients between long-term nitrate 
and THM concentrations were 0.03 (range 
–0.76 to 0.45) for total THMs, –0.41 (range 
–0.56 to 0.32) for chloroform, and 0.15 
(–0.72 to 0.56) for brominated THMs overall 
(minimum–maximum per area). To explore 
potential confounding by nitrate, we adjusted 
our main model additionally for nitrate. The 
point estimates varied minimally (data not 
shown), ruling out a major confounding effect 
of nitrate.
Selection bias might be a concern, 
particularly in Spain, where response rates 
were lower than those in Italy. The high 
response rate in Italy reflects traditionally 
high compliance of subjects approached 
for interview in the study’s hospital-based 
case–control network. In addition, controls 
were population-based in Spain but hospital-
based in Italy, explaining the lower response 
rates among controls in Spain. However, we 
assume that the probability of participation 
is independent from the exposure, and we 
do not expect an impact on the results from 
response rates. Study participants in Spain 
are part of a larger study in which a common 
pool of controls is shared for different cancer 
sites (colorectal, breast, prostate, stomach, 
lymphocytic chronic leukemia), leading to a 
larger number of controls than of cases and 
to slightly different age and sex distributions.
Metabolism of DBPs is mediated by 
enzymes from the GST and CYP families 
(DeMarini et al. 1997; Pegram et al. 1997; 
Raucy et al. 1993). In a previous study, 
we examined interactions between THM 
exposure and polymorphisms in two of the 
three genes that modified associations between 
THMs and bladder cancer (Cantor et al. 
2010). We found associations with polymor-
phisms in CYP2E1 that were not significant 
after correction for multiple comparisons. We 
did not find indications that polymorphisms 
in GSTZ modified the effects of exposure to 
brominated THMs. Although we evaluated 
gene–environment interactions in a large 
study, the analysis was limited by dichotomi-
zation of exposure, and our power to detect 
modest interactions after controlling for 
multiple comparisons remains limited.
Conclusions
Associations with colorectal cancer differed 
for estimated exposures to chloroform versus 
brominated THMs in residential drinking 
water in our case–control study. Our findings 
suggest a protective effect of chloroform, 
whereas a positive association with bromi-
nated THMs was observed among men at 
the extreme tail of the exposure distribution, 
where the results may have been driven by a 
small number of observations. Overall, these 
results require confirmation.
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